Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Some wound-healing cells can turn into fat cells around new hair growth in mice.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Genetic differences affect how people respond to COVID-19.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Type I interferons play a key role in the development of various skin diseases.

Keratin 15 affects cell behavior and characteristics in skin cells.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Biological factors are crucial for developing new hair restoration treatments.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Inflammation damages sweat ducts, causing sweat gland injury.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Red ginseng components help prevent skin aging by reducing inflammation and improving cell function.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.